Log In
BCIQ
Print this Print this
 

JNJ-53718678

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsTreat respiratory syncytial virus (RSV) infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today